TuHURA Biosciences (HURA) Research & Development (2012 - 2026)
TuHURA Biosciences' (HURA) quarterly Research & Development came in at $5.2 million in Q1 2026, up 14.21% year-on-year from $4.6 million in Q1 2025, and down 13.59% quarter-over-quarter from $6.1 million in Q4 2025.
TuHURA Biosciences (HURA) Research & Development (2012 - 2026) Analysis & Trends
TuHURA Biosciences' Research & Development history runs 15 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- On a quarterly basis, Research & Development rose 14.21% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $21.2 million, a 11.52% decrease from a year earlier, with the FY2025 full-year figure at $20.5 million, up 53.97% from the prior year.
- Research & Development retreated to $5.2 million in Q1 2026 per HURA's latest filing, from $6.1 million in the prior quarter.
- Across five years, Research & Development topped out at $9.4 million in Q3 2024 and bottomed at -$1.9 million in Q2 2023.
- The 5-year median for Research & Development is $3.6 million (2024), against an average of $3.9 million.
- Across the five-year window, Research & Development tumbled 47.23% in 2022 and jumped 445.11% in 2024, its largest moves.
- Year by year, Research & Development stood at $2.1 million in 2022, then decreased by 4.32% to $2.0 million in 2023, then soared by 375.07% to $9.4 million in 2024, then slumped by 35.3% to $6.1 million in 2025, then fell by 13.59% to $5.2 million in 2026.
- Per Business Quant, the three latest HURA Research & Development figures stand at $5.2 million (Q1 2026), $6.1 million (Q4 2025), and $5.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 343.97 Mn |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | 5.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.23 Mn |
| Dec 31, 2025 | 6.06 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 4.93 Mn |
| Mar 31, 2025 | 4.58 Mn |
| Sep 30, 2024 | 9.36 Mn |
| Jun 30, 2024 | 6.41 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | -1.86 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 2.06 Mn |
| Sep 30, 2022 | 3.17 Mn |
| Mar 31, 2022 | 3.47 Mn |
| Dec 31, 2021 | 3.90 Mn |
| Sep 30, 2021 | 3.79 Mn |
| Jun 30, 2021 | 4.03 Mn |
| Mar 31, 2021 | 3.84 Mn |
| Dec 31, 2020 | 2.58 Mn |